0001144204-07-062677.txt : 20071116 0001144204-07-062677.hdr.sgml : 20071116 20071116163630 ACCESSION NUMBER: 0001144204-07-062677 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20071106 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20071116 DATE AS OF CHANGE: 20071116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-23357 FILM NUMBER: 071253631 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETT STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 8-K 1 v094821_8k.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 6, 2007

BIOANALYTICAL SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Indiana		0-23357		35-1345024
(State or other jurisdiction of incorporation or organization)		(Commission File Number)		(I.R.S. Employer Identification No.)

2701 KENT AVENUE WEST LAFAYETTE, INDIANA		47906-1382
(Address of principal executive offices)		(Zip Code)

Registrant's telephone number, including area code: (765) 463-4527

Item 8.01. Other Events.

On November 15, 2007, the Board of Directors of Bioanalytical Systems, Inc. (the "Company") elected William B. Baitinger to be Chairman of the Board. Mr. Baitinger has served as a director of the Company since 1979.

On November 16, 2007, the Company issued a press release announcing Mr. Baitinger's election. The press release is attached hereto as Exhibit 99.1.

Item 9.01. Financial Statements and Exhibits.

	(a)	Not applicable.
	(b)	Not applicable.
	(c)	Not applicable.
	(d)	Exhibits.
	99.1	Press Release dated November 16, 2007.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	Bioanalytical Systems, Inc.

Date: November 16, 2007	By:	/s/ Michael R. Cox
		Michael R. Cox Vice President, Finance and Administration, and Chief Financial Officer

Exhibit No.	Description

99.1	Press Release dated November 16, 2007.

EX-99.1 2 v094821_ex99-1.htm

For more information: Michael R. Cox

765.463.4527

mcox@bioanalytical.com

BASi Announces Election of New Chairman of the Board

WEST LAFAYETTE, IN, November 16, 2007 — Bioanalytical Systems, Inc. (Nasdaq: BASI) announced today that its Board of Directors elected William Baitinger to be the Chairman of the Board.

Mr. Baitinger has served as a director of BASi since 1979. He replaces Peter T. Kissinger, Ph.D., who resigned from his office as Chairman of the Board in September of 2007.

President, Chief Executive Officer and Director Dick Shepperd noted that "I am pleased to announce Bill's election as Chairman of the Board. Bill brings a depth of knowledge of BASi, its business and its history that will be highly valuable to the Board of Directors. I look forward to working more closely with him going forward."

BASi is a contract research and research products company providing services and laboratory instruments to the world’s leading drug development companies and life science research organizations. The Company focuses on developing innovative services and products that increase efficiency and reduce costs associated with taking new drugs to market. Visit www.bioanalytical.com for more about BASi.

This release contains forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to board transition matters, the development of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company’s filings with the Securities and Exchange Commission.

# # # # #